本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tango Therapeutics Inc.

24.17
+0.36001.51%
盘前:24.260.0900+0.37%08:22 EDT
成交量:286.80万
成交额:6,908.42万
市值:40.85亿
市盈率:-28.77
高:24.47
开:23.57
低:23.34
收:23.81
52周最高:34.39
52周最低:6.69
股本:1.69亿
流通股本:1.21亿
量比:0.80
换手率:2.37%
股息:- -
股息率:- -
每股收益(TTM):-0.8400
每股收益(LYR):-0.8746
净资产收益率:-21.34%
总资产收益率:-12.99%
市净率:3.99
市盈率(LYR):-27.64

数据加载中...

2025/05/19

SEC问询函

Form CORRESP - Correspondence
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/28

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities